Clinical Trials
2 trialsNCT02226276 2026-02-13
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
City of Hope Medical Center
Phase NA Active not recruiting
NCT06299852 2024-03-08
Stereotactic Radiation Therapy for HE2-positive Oligometastatic Breast Cancer
N.N. Petrov National Medical Research Center of Oncology
Phase NA Unknown